Page 16 - GC America: The GC Experience - eMagazine for Dental Enthusiasts (April 2017)
P. 16

16
(continued)
bad for what had happened to this young girl. As I sat looking at this photo after the team had left that night, I was overwhelmed about what to do dentally for this young girl. Like most of us that are dealt with a case like this, we first look to see if there is at least one good thing that we can use to guide us through the restorative process. After staring at the screen for about twenty minutes and surveying all of the damage, I noticed that the occlusal surfaces of #18, #20, #21, #28 and #29 were nearly untouched whereas the tooth structure around the resin in #30 was destroyed. I reviewed my clinical notes only to discover that five years before, I had restored #18, #20, #21, #28 and #29 with GC Fuji IX GP glass ionomer in these occlusal regions. The #30 region that was restored with resin did not fare as well. All of the benefits of glass ionomer versus composite that I had known had actually worked amazingly well in these regions. She had gone from “low risk” to “high risk”. Having treated these teeth as “high risk” when at the time, she profiled as “low risk” had actually preserved tooth structure in this most challenging oral environment.
In conclusion, this case has reminded me that I never know what “risk path” a patient may go down over their lives. I can’t control their choices or the circumstances that affect their lives. However, I can be as diligent as I can in their dental diagnosis and choice of restorative materials. This case proves that this level of diligence does have benefit if for nothing else than these five isolated regions.
(Clinical Case Image courtesy of Dr. James C. Burden, DMD, FAGD)
Note from the author:
At the time of this article, GC America has launched EQUIA Forte (pictured on the next page), the next generation of Glass Ionomer Restoratives. It uses a combination of EQUIA Forte Fil (glass hybrid) and EQUIA Forte Coat (a filled resin coating). This allows for the expansion of indications to include load bearing Class II. I am currently evaluating this product on specific patients and will generate a case report in the very near future.


































































































   14   15   16   17   18